What is Catalonia…
  • Catalonia is…
    • Architecture
    • Cuisine
    • Medical Science
    • Science & Technology
    • Visual Arts
    • Business & Finance
    • Sport
    • Music & Performing Arts
    • Wine
    • Nature
    • Events
  • Travel
  • History
  • Blog
  • About
    • Contact Us
  • Buy the book!
  • Catalonia is…
    • Architecture
    • Cuisine
    • Medical Science
    • Science & Technology
    • Visual Arts
    • Business & Finance
    • Sport
    • Music & Performing Arts
    • Wine
    • Nature
    • Events
  • Travel
  • History
  • Blog
  • About
    • Contact Us
  • Buy the book!
What is Catalonia…
  • Catalonia is…
    • Architecture
    • Cuisine
    • Medical Science
    • Science & Technology
    • Visual Arts
    • Business & Finance
    • Sport
    • Music & Performing Arts
    • Wine
    • Nature
    • Events
  • Travel
  • History
  • Blog
  • About
    • Contact Us
  • Buy the book!
  • Catalonia is…
    • Architecture
    • Cuisine
    • Medical Science
    • Science & Technology
    • Visual Arts
    • Business & Finance
    • Sport
    • Music & Performing Arts
    • Wine
    • Nature
    • Events
  • Travel
  • History
  • Blog
  • About
    • Contact Us
  • Buy the book!
Home Blog Commitment brings breakthroughs in Cancer research and treatment

Commitment brings breakthroughs in Cancer research and treatment

20 March, 2018 No Comments

It takes dedication and hard work to yield results that benefit humanity, especially in the field of cancer research and treatment. These are qualities embedded in Catalan culture, so it is no surprise that many Catalans are recognised internationally for their contributions to oncology.

Four names are of particular note: Joan Massagué i Solé, Josep Baselga i Torres, Antoni Ribas i Bruguera and Manuel Esteller i Badosa.

Joan Massagué

Barcelona, 1953

The oncologist Joan Massagué is a researcher working in the fields of regulating cell division and metastasis of cancer. He has particularly focused on studying the signalling mechanisms that have proven to be essential for normal development of tissues and which are altered when cancer is present.

Massagué’s research has been decisive in understanding the mechanisms that prevent cell proliferation which, when uncontrolled, leads to the formation of tumours, and in contributing to the development of new drugs that can be used for various oncological indications.

His research has also led to identification of the genes which control metastasis of breast cancer tumour cells to other areas of the body and which cause the disease to spread, as well as the  development of pharmaceuticals which reduce the effects of chemotherapy in sufferers.

Since 2013 he has been director of the Memorial Sloan-Kettering Cancer Center in the city of New York. He is a member of the American Academy of Arts & Sciences, the National Academy of Sciences of the United States, the European Molecular Biology Organisation (EMBO), the Spanish Royal Academy of Medicine and the Spanish Royal Academy of Pharmacy.

 

Photo: Matthew Septimus [CC BY-SA 4.0 ], via Wikimedia Commons

Josep Baselga i Torres, Reial Acadèmia de Medicina de Catalunya and Memorial Sloan-Kettering Hospital, New York

Josep Baselga i Torres

Barcelona, 1959

The Barcelona oncologist Josep Baselga i Torres, currently the medical director of the Memorial Sloan-Kettering Hospital in New York, is recognised for his research in new breast cancer therapies and for his leadership to ensure that scientific progress reaches patients as quickly as possible.

In 2013 he became medical director of the Memorial Sloan-Kettering Hospital in New York. In 2014 he was elected president of the American Association for Cancer Research (AACR), the most important scientific organisation in the world of oncology.

The press release in which AACR announced his election noted that “he is an internationally recognised physician-scientist” who has developed «innovative anti-cancer treatments which attack various molecules». “His work”, the note adds, “helped to introduce various new drugs including Trastuzumab and Lapatinib”, two compounds which have improved treatment for hundreds of thousands of women with breast cancer.

He has received the Honorary Membership Award of the European Society for Therapeutic Radiology and Oncology (ESTRO), the Statesman Award of the American Society of Clinical Oncology (ASCO), among many other distinctions.

 

Photo: Real Acadèmia de Medicina de Catalunya

Antoni Ribas i Bruguera

Barcelona, 1956

Fellow oncologist Antoni Ribas has become a world leader in the development of new immunotherapy treatments against metastatic melanoma (the most fatal form of skin cancer which spreads through the body), which have been used as the basis for research into other cancer types.

He works to reprogram the immune system against cancer, based on the principle that our immune system already has the ability to recognise and destroy cancerous cells, yet these cells develop a defence mechanism and hide from the immune system. Immunotherapy is used to block this hiding mechanism used by cancerous cells, so that the immune system recovers its capacity to recognise and destroy them. The journal Science named oncological immunotherapy as the most important scientific discovery of 2013.

He is director of the tumour immunology programme at the Jonsson Comprehensive Cancer Center, connected to UCLA, and is vice president of the Society for Melanoma Research (SMR), the most important international melanoma research society.

He is named as inventor in seven American patents, and has won approval from the Food and Drugs Administration to trial seventeen new drugs resulting from the research on applying clinical treatments. 

 

Manuel Esteller i Badosa

Sant Boi de Llobregat, 1968

Since 2008, Manuel Esteller has been director of the Epigenetics and Biology of Cancer Programme of Bellvitge Bio- medical Research Institute (IDIBELL) and head of the Epigenetics of Cancer Research Group.

His research is currently focused on establishing epigenome maps of normal and transformed cells, the study of epigenetic modifications and non-coding RNAs, along with the development of new epigenetic drugs for treating cancer.

In 2011 a study coordinated by Esteller, working at IDIBELL, discovered a substance which prevents the growth of cancer by means of activating the so-called dark genome (or non-coding DNA) and microRNA molecules. The study was published in the prestigious scientific journal Proceedings of the National Academy of Sciences.

As recently as 2014, IDIBELL researchers led by Manuel Esteller have also identified the mechanism which converts tumour cells into glucose addicts. This substance, glucose, causes the fast development of the tumour, as it becomes the fuel used to multiply cells quickly. The door has thus been opened to researching, whether by inhibiting this dependence or blocking this energy source with drugs, how the tumour could be made to die, as a result of not having energy to reproduce.



biomedical research cancer life sciences
« Previous
Next »
Leave a Reply

Click here to cancel reply.

Who we are

What is Catalonia… is a non-profit website set up in March 2018 by people passionate about answering all your questions about wonderful Catalonia. If your question hasn’t been answered yet, keep checking for new content or contact us!

common questions
Where is Catalonia?
Catalonia is located between the Pyrenees mountain range and Mediterranean Sea. Bordering with France to the north...Read more
Why does Catalonia want independence?
How long have you got? This is clearly a complex issue and one that has a thousand years of answers...Read more
What are the top things to see in Catalonia?
Catalonia is full of amazing destinations, both well-known and hidden gems. We are running a mini-survey to find out what Catalans think are the most iconic or emblematic and representative of their country.
We will be publishing our Top 10 must-see destinations soon - keep checking back or sign up to our mailing list for updates!
Like us on facebook!
  • Facebook
  • Twitter
  • Google+
  • YouTube
  • LinkedIn
  • Pinterest
Galleries
Barcelona

City

Mountains

Nature

Wine

Special interest

Golf

Sport

Recent Posts
  • My home will always be your home…
  • Catalonia vs Spain
  • What has Catalonia ever done for us?
  • Barcelona Games World
  • The Financial Times Group selects Catalonia as the best Southern European region for investment in 2018 and 2019
About Us

What is Catalonia… is a non-profit initiative of the Occitano-Catalan Foundation in partnership with other organisations and English natives living Catalonia, with the aim of helping the world understand more about this open and culturally and historically rich country.

We are Catalonia
Contact Us
FUNDACIÓ OCCITANO CATALANA
Via Laietana, 39, 3a planta
08003 Barcelona

  Phone: +34 93 412 1014
  Fax: +34 93 3174 828
  Mail: info@whatiscatalonia.org
A land of possibilities
Created by Arthur Kendall
© Fundació Occitano Catalana / Arthur Kendall / Pagès Editors. All rights reserved.
Scroll to top
Skip to content
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset